BioSpace News Archive

Pharm Country

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

In addition, Fortress has granted the underwriters a 30-day option to purchase up to 150,000 additional shares at the public offering price, less underwriting discounts and commissions.

November 7, 2017

·

4 min read

Policy

Sarepta Therapeutics Announces FDA Clearance of IND for the Company’s PPMO Exon 51 Candidate, SRP-5051

Sarepta to immediately initiate a Phase 1/2a clinical trial in patients with Duchenne muscular dystrophy (DMD) amenable to skipping exon 51.

November 7, 2017

·

8 min read

Business

Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

The Company reported a net loss of $7.6 million, or $0.22 per share, compared to a net loss of $4.2 million, or $0.30 per share, in the third quarter ended September 30, 2016.

November 7, 2017

·

10 min read

Business

Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results

Evoke will hold a conference call on Tuesday, November 14, 2017 at 4:30 pm ET to discuss the results.

November 7, 2017

·

1 min read

Drug Development

Cellectar Announces Updated Median Overall Survival of 26.2 Months from Cohort 1 of CLR 131 Phase I Trial in Advanced Multiple Myeloma

While no head-to-head studies have been conducted for comparison, the median overall survival benefit seen with the three most recently FDA-approved third line therapies for multiple myeloma ranges from 11.9 – 18.6 months in separate trials.

November 7, 2017

·

5 min read

Biotech Beach

The Scripps Research Institute Scientists Find Potential “Missing Link” in Chemistry That Led to Life on Earth

Chemists at The Scripps Research Institute have found a compound that may have been a crucial factor in the origins of life on Earth.

November 7, 2017

·

4 min read

Business

Skyline Medical Expands International Presence by Signing Distribution Agreements in Canada and Switzerland

Securing the extensive sales and marketing capabilities of these distributors will allow Skyline to penetrate the Switzerland market for the first time and expand its presence in Canada.

November 7, 2017

·

5 min read

Business

Biomerica Extends Exclusive License Agreement With Celtis Pharm (Telcon Pharmaceuticals) to December 2019

Previously announced Korean deal valued at up to $8.5 million.

November 7, 2017

·

5 min read

Biotech Beach

Neurelis Expands Worldwide Patent Portfolio With Latest Issuance inn Japan

The patent, when issued, will be in force at least until 2032.

November 7, 2017

·

3 min read

BioForest

LumiThera Unveils LIGHTSITE I Dry AMD Clinical Interim Data

The 30-subject pilot study funded from a SBIR grant awarded to the Company from the NIH and the National Eye Institute is testing each subject’s vision and examining disease pathology in the eye, following PBM treatments for up to one year.

November 7, 2017

·

2 min read